XML 42 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest in Subsidiary
Beginning Balance (in shares) at Dec. 31, 2016   32,339,000        
Beginning Balance at Dec. 31, 2016 $ 151,802 $ 3 $ 256,570 $ (1,241) $ (104,089) $ 559
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares)   41,000        
Vesting of restricted stock and performance stock awards (in shares)   282,000        
Vesting of restricted stock and performance stock awards (1,774)   (1,774)      
Shares issued for Convertible Notes (in shares)   3,176,000        
Shares issued for Convertible Notes 45,952 $ 1 45,951      
Equity compensation 4,080   4,080      
Cumulative-effect adjustment - share-based compensation     535   (535)  
Foreign currency translation adjustment, net of taxes $ 75     75    
Stock repurchase and retirement (in shares) 0          
Distribution to noncontrolling shareholder $ (1,218)         (1,218)
Net (loss) income 38,802       37,513 1,289
Ending Balance (in shares) at Dec. 31, 2017   35,838,000        
Ending Balance at Dec. 31, 2017 237,719 $ 4 305,362 (1,166) (67,111) 630
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares)   21,000        
Vesting of restricted stock and performance stock awards (in shares)   199,000        
Vesting of restricted stock and performance stock awards (889)   (889)      
Equity compensation 3,575   3,575      
Foreign currency translation adjustment, net of taxes $ (121)     (121)    
Stock repurchase and retirement (in shares) 0 (432,439)        
Stock repurchase and retirement $ (5,000) $ (5,000) (5,000)      
Net change in hedging transaction, net of taxes (175)     (175)    
Distribution to noncontrolling shareholder (1,194)         (1,194)
Net (loss) income (15,717)       (16,951) 1,234
Ending Balance (in shares) at Dec. 31, 2018   35,626,000        
Ending Balance at Dec. 31, 2018 $ 218,198 $ 4 303,048 (1,462) (84,062) 670
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares) 32,500 14,000        
Vesting of restricted stock and performance stock awards (in shares)   231,000        
Vesting of restricted stock and performance stock awards $ (801)   (801)      
Equity compensation 3,396   3,396      
Foreign currency translation adjustment, net of taxes 47     47    
Net change in hedging transaction, net of taxes 175     175    
Distribution to noncontrolling shareholder (1,572)         (1,572)
Net (loss) income (55,943)       (57,713) 1,770
Ending Balance (in shares) at Dec. 31, 2019   35,871,000        
Ending Balance at Dec. 31, 2019 $ 163,500 $ 4 $ 305,643 $ (1,240) $ (141,775) $ 868